From Medscape Dermatology

Coverage from the

American Academy of Dermatology (AAD) 2017 Summer Meeting

July 27 - 30, 2017; New York, NY

July 27 - 30, 2017 New York, NY

Conference News

Popular News from AAD 2017 Annual Meeting

  • Low Vitamin D Concerns Lead to Overtesting and Overtreatment Low Vitamin D Concerns Lead to Overtesting and Overtreatment Supplements are safe and cheap, while tests can be expensive and inconsistent, experts said. They also addressed controversies around how much vitamin D is necessary and its association with diseases.
  • JAK Inhibitors Show Promise for Alopecia, Eczema, Vitiligo JAK Inhibitors Show Promise for Alopecia, Eczema, Vitiligo A researcher at the forefront shares promising results from small studies. Clinical trials are in progress and he predicts FDA approval for a JAK inhibitor for alopecia and eczema within 3 years.
  • New Topical for Mild to Moderate Psoriasis in the Works New Topical for Mild to Moderate Psoriasis in the Works It's been decades since a new topical option has been available for mild-to-moderate psoriasis, but a new agent shows promise in a phase 3 trial presented as a late-breaker at the AAD Annual Meeting.

Medscape Dermatology©  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.